Keeping ahead of the resistance curve: Product bundling to conserve artemisinin-based combination therapy

Osman Dar; Sakib Rokadiya; David L. Heymann

doi:10.1016/S2214-109X(15)70018-5

Keeping ahead of the resistance curve: Product bundling to conserve artemisinin-based combination therapy

Osman Dar
, Sakib Rokadiya
, David L. Heymann^*

^*Corresponding author for this work

Global Public Health Consultants

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	e304-e305
Journal	The Lancet Global Health
Volume	3
Issue number	6
DOIs	https://doi.org/10.1016/S2214-109X(15)70018-5
Publication status	Published - 1 Jun 2015

Access to Document

10.1016/S2214-109X(15)70018-5

Cite this

@article{03047819fdb04204abe6af4632ed9c40,

title = "Keeping ahead of the resistance curve: Product bundling to conserve artemisinin-based combination therapy",

author = "Osman Dar and Sakib Rokadiya and Heymann, \{David L.\}",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/S2214-109X(15)70018-5",

language = "English",

volume = "3",

pages = "e304--e305",

journal = "The Lancet Global Health",

issn = "2572-116X",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Keeping ahead of the resistance curve

T2 - Product bundling to conserve artemisinin-based combination therapy

AU - Dar, Osman

AU - Rokadiya, Sakib

AU - Heymann, David L.

PY - 2015/6/1

Y1 - 2015/6/1

UR - https://www.scopus.com/pages/publications/84930378428

U2 - 10.1016/S2214-109X(15)70018-5

DO - 10.1016/S2214-109X(15)70018-5

M3 - Comment/debate

C2 - 25920814

AN - SCOPUS:84930378428

SN - 2572-116X

VL - 3

SP - e304-e305

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 6

ER -

Keeping ahead of the resistance curve: Product bundling to conserve artemisinin-based combination therapy

Access to Document

Other files and links

Cite this